FDA Investigator Brandy N Lepage

Brandy N Lepage has conducted inspections on 41 sites in 5 countries as of 10 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
41
Last Inspection Date:
10 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, China, Canada, India, Italy
FDA Investigators that have inspected at least one site in common with Brandy N Lepage:
Alan L Truong, Albert A Salvador, Alice S Tsao, Anastasia M Shields, Anh M Lac, Anita R Michael, Ann Marie Montemurro, Anthony C Warchut, Ariel Cruz Figueroa, Audrey Thereset Uy, Barbara J Rincon, Ben Du, Bijoy Panicker, Bonita S Chester, Carl A Huffman, III, Caryn M Mcnab, CDR Rochelle B Young, RPh, MSA, Charanjeet Jassal, Charisse K Green, Christian D Lynch (CDL), Christian Parra, Christina K Theodorou, Christina Theodorou, Courtney N Long, Craig D Zagata, Cynthia J Lee, MS, Cynthia White, Daniel J Grabicki, Daniel J Min, Daniel L Zheng, Daniel T Lee, Daryl A Dewoskin, David A Carlson, David J Hafner, David R Delucia, Debra L Pagano, Demitria J Argiropoulos, Demitria J Xiradakis, Denise M Digiulio, Dennis R Hock, Diane C Thibodeau, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Dr. Mark J Seaton, PhD, Dr. Robert C Horan, MD, Dr. Zhihao Qiu (Peter), PhD, Edmund F Mrak, Jr, Edward D Mcdonald, Edward J Janik, Eileen A Liu, Emest F Bizjak, Emmanuel Jramos Maldonado, Erika M Wilkerson, Erin I Keith, Frederick F Razzaghi, Gale L Glinecki, Gam S Zamil, Gary J Lehr, Gary T Greco, Gayle S Lawson, Geraldine D Sanders, Guerlain Ulysse, Gwyn G Dickinson, Hala L Selby, Helen B Ricalde, Helen Verdel, Irina Gaberman, Ivis L Negron, Ivy E Sweeney, Jacqueline Mdiaz Albertini, James A Liubicich, James D Bridges, James M Mason, Janet L Bowen, Jay T Wong, Jeffrey J Thibodeau, Jennifer L Huntington, Jesse P Hardin, Jessica L Pressley, Jessica S Estriplet, Joanne Hajoway, Joanne M Hajoway, Joanne M Schlossin, Jogy George, Jonathan G Matrisciano, Jose Acruz Gonzalez, Jose Ohernandez Guzman, Joseph J Vannelli, Joseph L Despins, PhD, Joseph Maselli, Joseph R Lambert, Juan Rjimenez Garcia, Juliana M Badalucco, Julianne C Mccullough, Justin A Boyd, Kara D Dobbin, Karen A Briggs, Karen L Kosar, Karyn M Campbell, Katherine Szestypalow, Kelli F Dobilas, Kenneth H Williams, Kevin A Gonzalez, Ko U Min, Kristina J Donohue, Laura Fontan, MS, Lawrence W Farina, LCDR Debra Emerson, LCDR Susan E Polifko, LCDR Wilfred A Darang, Li Li, LTJG Bradley E Benasutti, Marcelo O Mangalindan, Jr, Margaret E Sarles, Maria A Reed, Marie Elena C Puleo, Mark R Mcclain, Marlene G Swider, Martha Sullivan Myrick, Mary R Kirker, Matthew D Schnittker, Maya M Davis, Melissa D Ray, Melissa J Garcia, Meredith P Soehl, Investigator, Merideth K Rose, Michael A Charles, Michael D Omeara, Michael E Maselli, Michael Levin, Michael Shanks, MS, Michael W Burd, Michele Gottshall, Michele M Falchek, Mihaly S Ligmond, Mindy M Chou, Mra Davism, Mra M Barbosar, Murthy Vkn Sikha, Nancy M Espinal, Nazmul Hassan, Nealie C Newberger, Nebil A Oumer, Neil J Bonzagni, PhD MPH, Nerizza B Guerin, Niketa Patel, Noreen Muñiz, Omadevi Somai, Investigator, Omotunde O Osunsanmi, Parul M Patel, Patrick C Klotzbuecher, Patsy J Domingo, Paul A Bonneau, Paul E Stein, Paul Mouris, Peter E Baker, Peter R Lenahan, Philip F Istafanos, DMV, MS, Phyllis J Wilson, Prabhu P Raju, Qin Xu, Rachael A Moliver, Raihan A Chowdhury, Reba A Gates, Regina T Brown, Richard K Glabach, Richard L Friedman, Richard Ledwidge (nmi), PhD, Robert C Steyert, Robert J Maffei, Robert J Martin, Robert L Lewis, Jr, Robert M Barbosa, Roseline N Boateng, Ruben C Quintana, S Lori Brown, PhD MPH, Samina S Khan, Samir C Gala, Samuel T Walker, Sangeeta M Khurana, PhD, Sarah A Meehan, Sarah E Mcmullen, Satheesh Thomas, Scott T Ballard, Sean R Marcsisin, Sena G Dissmeyer, Shusheen A Alexander, Sidney B Priesmeyer, Simone E Pitts, Sony Mathews, Stephanie Mangigian, MS/OSH, RN, Stephen D Brown, Stephen J Koniers, Stephen J Mottola, Stephen R Souza, Steven C Madzo, Steven L Carter, Steven M Weinman, Steven P Donald, Susan F Laska, MS, Susan M Jackson, Susan M Joseph, Susan P Bruederle, Susan W Ting, Susanna E Ford, Syeda N Mahazabin, Tammy L Chavis, Tania E Vizcaino, Tanya R Syffrard, Teresa I Navas, Terry Bridgewater, Thai D Truong, Thomas J Arista, Thomas J Mooney, Thomas P Hansen, Thomas R Withers, Tiffani D Wilson, Torrance J Slayton, Tracy M Portelli, Travis R Hunt, Uduak M Inokon, Unnee Ranjan, Viviana Matta, Vivin George, Vlada Matusovsky, Warren J Lopicka, Wayne E Seifert, Wayne T Smith, Yasamin Ameri, Yumi J Hiramine, Yuyan Liang, Yvette I Henry, Yvette I Johnson, Zakaria I Ganiyu, Zhong Li, PhD, Zhongren Wu

Brandy N Lepage's Documents

Publish Date Document Type Title
February, 2022 FDA 483 Almac Pharma Services LLC - Form 483, 2022-02-03
February, 2022 EIR Almac Pharma Services LLC - EIR, 2022-02-03
November, 2022 FDA 483 RemedyRepack, Inc - Form 483, 2022-11-10
July, 2021 EIR LNK International, Inc. - EIR, 2021-07-01
August, 2023 FDA 483 Coupler LLC - Form 483, 2023-08-10
March, 2022 FDA 483 CooperSurgical, Inc. - Form 483, 2022-03-04
February, 2024 FDA 483 Gehring-Montgomery, Inc - Form 483, 2024-02-09
March, 2022 EIR CooperSurgical, Inc. - EIR, 2022-03-18
May, 2023 FDA 483 Patheon Italia S.p.A - Form 483, 2023-05-26
October, 2021 FDA 483 Boiron Inc. - Form 483, 2021-10-25
December, 2022 FDA 483 Sentara Infusion Services - Form 483, 2022-12-16
October, 2023 FDA 483 Quotient Sciences - Philadelphia, LLC - Form 483, 2023-10-27
August, 2021 FDA 483 Aplicare Products, LLC - Form 483, 2021-08-03
July, 2023 FDA 483 Keystone Industries - Form 483, 2023-07-20
March, 2021 FDA 483 Evaric Pharmaceuticals Inc - Form 483, 2021-03-01
January, 2024 FDA 483 Chartwell Pharmaceutical Carmel LLC - Form 483, 2024-01-11
July, 2021 FDA 483 Response LNK International, Inc. - Form 483R, 2021-07-23
April, 2023 FDA 483 Copperhead Chemical Company Inc. - Form 483, 2023-04-24
January, 2024 FDA 483 Charles River Laboratories, Inc. - Form 483, 2024-01-04
November, 2022 FDA 483 Teva Pharmaceuticals USA, Inc. - Form 483, 2022-11-10
July, 2021 FDA 483 LNK International, Inc. - Form 483, 2021-07-01
March, 2022 FDA 483 Precision Nuclear of Virginia - Form 483, 2022-03-25
October, 2022 FDA 483 Chartwell Pharmaceuticals Carmel, LLC - Form 483, 2022-10-06
May, 2021 FDA 483 Apothecus Pharmaceutical Corp. - Form 483, 2021-05-17
November, 2021 FDA 483 Response ULTRAtab Laboratories, Inc. - Form 483R, 2021-10-05
August, 2022 EIR Quotient Sciences - Philadelphia, LLC - EIR, 2022-08-16
January, 2023 FDA 483 PACKAGING COORDINATORS LLC - Form 483, 2023-01-12
April, 2022 FDA 483 Contract Pharmacal Corp. - Form 483, 2022-04-14
March, 2022 FDA 483 Response CooperSurgical, Inc. - Form 483R, 2022-03-21
June, 2022 FDA 483 Jerome Stevens Pharmaceuticals, Inc. - Form 483, 2022-06-15
May, 2022 FDA 483 Aphena Pharma Solutions - Maryland, LLC - Form 483, 2022-05-06
August, 2022 FDA 483 Quotient Sciences - Philadelphia, LLC - Form 483, 2022-08-16
June, 2021 FDA 483 HomeoCare Laboratories Inc. - Form 483, 2021-06-04
November, 2021 FDA 483 ULTRAtab Laboratories, Inc. - Form 483, 2021-09-14
June, 2024 FDA 483 BIOCON BIOSPHERE LIMITED - Form 483, 2024-06-14
September, 2021 FDA 483 ULTRA-tab Laboratories, Inc. - Form 483, 2021-09-14
May, 2024 FDA 483 RK PHARMA INC - Form 483, 2024-05-31
June, 2024 FDA 483 BIOCON LIMITED - Form 483, 2024-06-21
January, 2024 FDA 483 Chartwell Pharmaceuticals Carmel, LLC - Form 483, 2024-01-11

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more